On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...